Sodium lauryl sulfoacetate
Classification: BATC code: A06AG11
Summary
Controlled studies on differences between men and women in sodium lauryl sulphate efficacy and safety are lacking
.
The present evidence concerning differences between men and women is limited and do not motivate differentiation in dosing or treatment.
Additional information
Pharmacokinetics and dosing
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of sodium lauryl sulphate have been found.
Effects
No studies with a clinically relevant sex analysis regarding the effects of sodium lauryl sulphate have been found.
Adverse effects
The skin irritability of volunteers to sodium lauryl sulphate (2% aqueous) has been studied by measuring skin vapour loss (SVL) (23 men, 15 women). The study found that female skin is more easily irritated [1].
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2015-08-20
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson